Skip to content

CorMedix CRMD Retained Earnings

Retained Earnings at other companies

Pfizer logo
PfizerPFE
$117.24B-2.0%
Merck & Co. logo
Merck & Co.MRK
$66.72B+0.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$865.03M+19.2%
ITG
Integer HoldingsITGR
$1.01B+16.3%
IAR
Integra LifeSciencesIART
$418.82M-54.2%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
-$153M-6.0%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's retained earnings?
CorMedix (CRMD) reported retained earnings of -$137.97M in Q1 2026.
How has CorMedix's retained earnings changed year-over-year?
CorMedix's retained earnings increased by 56.7% year-over-year, from -$318.99M to -$137.97M.
What is the long-term trend for CorMedix's retained earnings?
Over 5 years (2020 to 2025), CorMedix's retained earnings has grown at a -4.1% compound annual growth rate (CAGR), from -$217.45M to -$176.58M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.